• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. G2 EXPRESS FILTER SYSTEM - FEMORAL; VENA CAVA FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. G2 EXPRESS FILTER SYSTEM - FEMORAL; VENA CAVA FILTER Back to Search Results
Catalog Number RF400F
Device Problems Malposition of Device (2616); Patient Device Interaction Problem (4001)
Patient Problems Pulmonary Embolism (1498); Abdominal Pain (1685)
Event Date 08/10/2010
Event Type  Injury  
Manufacturer Narrative
Manufacturing review: a lot history review was performed.This is the only complaint to date for this lot number.Therefore, a device history record review is not required.Investigation summary: the device was not returned for evaluation.Medical records were provided and reviewed.Approximately one year and five months, post filter deployment computed tomography revealed right lower lobe subsegmental intraluminal filling defect suggests pulmonary embolus.Approximately two months later, computed tomography revealed right lower lobe subsegmental pulmonary embolus.Approximately one month later, computed tomography revealed right lower lobe subsegmental pulmonary arterial filling defect consistent.Approximately one year later, computed tomography revealed a small subsegmental intraluminal filling defect was seen in the right lower lobe.Approximately seven years later, computed tomography revealed the filter nose touched the right lateral wall at the level below the renal vessels with approximately 17 degrees of tilt.One leg extends through the left anterior wall extended 1 cm to the level anterior to the aorta.One posterior leg extends along the posterior wall of the aorta approximately 1.6 cm from the inferior vena cava wall.One leg from the mid left lateral wall extends 1 mm into the right lateral aortic wall.Therefore, the investigation is confirmed for perforation of the inferior vena cava (ivc) and filter tilt.Additionally, it can be confirmed that the patient experienced pulmonary embolism post deployment.However, the relationship to the filter is unknown.Based upon the available information, the definitive root cause is unknown.Labeling review: a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, and unit label) showed that the product labeling is adequate.Expiry date: 11/2011 the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient after being diagnosed with pulmonary embolism.At some time, post filter deployment, it was alleged that the filter tilted, and struts perforated.The device has not been removed and there were no reported attempts made to retrieve the filter.The patient reportedly experienced abdominal pain and diagnosed with pulmonary embolism; however, the current status of the patient is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
G2 EXPRESS FILTER SYSTEM - FEMORAL
Type of Device
VENA CAVA FILTER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer Contact
judith ludwig
1415 w. 3rd street
tempe, AZ 85281
4803032689
MDR Report Key11377103
MDR Text Key233452452
Report Number2020394-2021-80200
Device Sequence Number1
Product Code DTK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K080668
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,health professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 02/25/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/25/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberRF400F
Device Lot NumberGFSJ3305
Was Device Available for Evaluation? No
Date Manufacturer Received01/29/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
LIPITOR, CLONIDINE, SEROQUEL, LISINOPRIL, COUMADIN; LOVENOX, PRAVASTATIN, RANITIDINE, ALBUTEROL; MIRALAX, AND ZOFRAN
Patient Outcome(s) Life Threatening; Other;
Patient Age47 YR
Patient Weight76
-
-